-+ 0.00%
-+ 0.00%
-+ 0.00%

MABWELL'S ADALIMUMAB BIOSIMILAR RECEIVES MARKETING APPROVAL IN INDONESIA

Reuters·12/31/2025 14:00:06

Please log in to view news